# Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

> **NCT03793400** · — · COMPLETED · sponsor: **Changhua Christian Hospital** · enrollment: 22 (actual)

## Conditions studied

- Choroidal Neovascularization
- Punctate Inner Choroidopathy

## Interventions

- **DRUG:** Bevacizumab Injection

## Key facts

- **NCT ID:** NCT03793400
- **Lead sponsor:** Changhua Christian Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-13
- **Primary completion:** 2018-04-13
- **Final completion:** 2018-12-28
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03793400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03793400, "Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT03793400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*